Fig. 4: AOAA treatment reduces expression of VEGF-R2 and VEGF-R3 in HDLECs without major effects on VEGF-C and VEGF-D. | Communications Biology

Fig. 4: AOAA treatment reduces expression of VEGF-R2 and VEGF-R3 in HDLECs without major effects on VEGF-C and VEGF-D.

From: Cystathionine β-synthase as novel endogenous regulator of lymphangiogenesis via modulating VEGF receptor 2 and 3

Fig. 4

HDLECs were treated with indicated concentrations of AOAA for 24 h. Level of mRNA for (a) VEGF-C, and VEGF-D, (b) VEGF-R2, and VEGF-R3 was assessed using real-time PCR. Data are presented as means ± SEM. Statistical significance was analyzed with two-tailed t-test (n = 5). **p < 0.01; ***p < 0.001.

Back to article page